Evidence map›Paper›PMID 31637342›Full record

ArticleJournal of the Endocrine Society2019

Predictors of Clinical Success After Surgery for Primary Aldosteronism in the Japanese Nationwide Cohort.

Mitsuha Morisaki, Isao Kurihara, Hiroshi Itoh, Mitsuhide Naruse, Yoshiyu Takeda, Takuyuki Katabami, Takamasa Ichijo, Norio Wada, Takanobu Yoshimoto, Yoshihiro Ogawa and 10 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Sexual dimorphism in benign adrenocortical tumours.European journal of endocrinology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. [Risk factors of persistent hypertension in primary aldosteronism patients after surgery].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Best Achievements in Pituitary and Adrenal Diseases in 2020.Endocrinology and metabolism (Seoul, Korea) · 2021
    Review
  19. Pathogenesis and treatment of primary aldosteronism.Nature reviews. Endocrinology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 1 country.

Mitsuha MorisakiDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0001-9589-9140
Isao KuriharaDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0002-1782-8643
Hiroshi ItohDepartment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Mitsuhide NaruseDepartment of Endocrinology and Metabolism, National NHO Kyoto Medical Center, Kyoto, Japan.
Yoshiyu TakedaDepartment of Internal Medicine, Kanazawa University, Kanazawa, Japan.
Takuyuki KatabamiDivision of Metabolism and Endocrinology, St. Marianna University Yokohama City Seibu Hospital, Yokohama, Japan.
Takamasa IchijoDepartment of Endocrinology and Metabolism, Saiseikai Yokohama-shi Tobu Hospital, Yokohama, Japan.
Norio WadaDepartment of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo, Japan.
Takanobu YoshimotoDepartment of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan.
Yoshihiro OgawaDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Tokyo, Japan.
Masakatsu SoneDepartment of Diabetes, Endocrinology and Nutrition, Kyoto University, Kyoto, Japan.
Mika TsuikiDepartment of Endocrinology and Metabolism, National NHO Kyoto Medical Center, Kyoto, Japan.
Hirotaka ShibataDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan.
Junji KawashimaDepartment of Metabolic Medicine, Faculty of Life Science, Kumamoto University, Kumamoto, Japan.
Megumi FujitaDivision of Nephrology and Endocrinology, the University of Tokyo, Tokyo, Japan.
Minemori WatanabeDepartment of Endocrinology and Diabetes, Okazaki City Hospital, Okazak, Japan.
Yuichi MatsudaDepartment of Cardiology, Sanda City Hospital, Sanda, Japan.
Hiroki KobayashiDepartment of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine, Tokyo, Japan.
Tomoko SuzukiDepartment of Public Health, International University of Health and Welfare, Narita, Japan.
JPAS Study Group
Keio University · JPKyoto Medical Center · JPInternational University of Health and Welfare · JPKanazawa University · JPKumamoto University · JPKyoto University · JPKyushu University · JPNihon University · JPOita University · JPOkazaki City Hospital · JPSanden (Japan) · JPSapporo City General Hospital · JPThe University of Tokyo · JPTokyo Medical and Dental University · JPYokohama City Seibu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextAldosterone-producing adenomas are a curable subtype of primary aldosteronism (PA); however, hypertension persists in some patients after adrenalectomy.

objectiveTo identify factors associated with, and develop prediction models for, blood pressure (BP) normalization or improvement after adrenalectomy.

designRetrospective analysis of patients treated between 2006 and 2018, with a 6-month follow-up.

settingA nationwide, 29-center Japanese registry encompassing 15 university hospitals and 14 city hospitals. PATIENTS: We categorized 574 participants in the Japan Primary Aldosteronism Study, who were diagnosed with PA and underwent adrenalectomy, as BP normalized or improved, on the basis of their presentations at 6 months postsurgery.

main outcome measureThe rate of complete, partial, and absent clinical success. Predictive factors related to BP outcomes after PA surgery were also evaluated.

resultsComplete clinical success was achieved in 32.6% and partial clinical success was achieved in 53.0% of the patients at 6 months postsurgery. The following five variables were independent predictors for BP normalization: ≤7 years of hypertension, body mass index ≤25 kg/m

conclusionWe established models that predicted postoperative BP normalization in patients with PA. These should be useful for shared decision-making regarding adrenalectomy for PA.

Indexed as

curehypertensionimprovementpredictive modelprimary aldosteronismsurgery

Identifiers

PMID31637342
PMCPMC6795022
OpenAlexW2969431463

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.